Clinical Trials Browser

Phase 2 × Retinoblastoma × trioctyl phosphine oxide × Clear all

NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma